Lexeo Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $5.40 |
Previous Close | $5.35 |
Day Range | $5.40-$7.26 |
52W Range | $1.45-$11.29 |
Market Cap | $286.7M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$73.6M |
Diluted EPS | -$3.21 |
News
See moreYahoo Finance • last month
Lexeo Therapeutics stock price target lowered to $9 at H.C. Wainwright
Yahoo Finance • last month
Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights
Yahoo Finance • 3 months ago
Stifel reiterates Buy rating on Lexeo Therapeutics stock at $21 price target
Yahoo Finance • 3 months ago
Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia
About
CEO | Mr. R. Nolan Townsend |
CFO | Mr. Louis Tamayo |
Address | 345 Park Avenue South, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |
